Skip to main content Accessibility help
×
×
Home
  • Print publication year: 2011
  • Online publication date: November 2011

14 - The neural basis for the acute effects of cannabis on learning and psychosis

Summary

This chapter surveys possible lasting consequences of cannabinoid exposure during crucial periods of pubertal and adolescent maturation reported from animal studies. Endocannabinoids and their cannabinoid receptors, CB1 and CB2, are present from the early stages of gestation and play a number of vital roles for the developing organism. Beside direct alterations in the endocannabinoid or other neurotransmitter systems, adolescent/pubertal cannabinoid exposure has been reported to affect cortical and limbic systems in particular. Global evidence indicates that cannabis use/abuse acts as a risk factor for the emergence of schizophrenia, especially among early-onset cannabis users. Similar indications were observed in animal studies, where chronic pubertal, but not adult, cannabinoid treatment resulted in lasting behavioral deficits, resembling at least some aspects of schizophrenia. Data from animal research point out clearly that the age at which an individual is exposed to cannabinoids has major impact on subsequent effects of this drug.
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Marijuana and Madness
  • Online ISBN: 9780511706080
  • Book DOI: https://doi.org/10.1017/CBO9780511706080
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

Allen, P., Aleman, A. and McGuire, P.K. (2007) Inner speech models of auditory verbal hallucinations: evidence from behavioral and neuroimaging studies. Int Rev Psychiatry, 19:407–15.
Aron, A.R., Fletcher, P.C., Bullmore, E.T., Sahakian, B.J. and Robbins, T.W. (2003) Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci, 6:115–6.
Bhattacharyya, S., Crippa, J.A., Martin-Santos, R., Winton-Brown, T. and Fusar-Poli, P. (2009a) Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des, 15:2603–14.
Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., et al. (2009b) Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry, 66:442–51.
Bhattacharyya, S., Morrison, P.D., Fusar-Poli, P., et al. (2010) Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology, 35:764–74.
Borgwardt, S.J., Allen, P., Bhattacharyya, S., et al. (2008) Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry, 64:966–73.
Bossong, M.G., van Berckel, B.N., Boellard, R., et al. (2009) Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology, 34:759–66.
Brewer, J.B., Zhao, Z., Desmond, J.E., Glover, G.H. and Gabrieli, J.D. (1998) Making memories: brain activity that predicts how well visual experience will be remembered. Science, 281:1185–7.
Buckner, R.L. and Wheeler, M.E. (2001) The cognitive neuroscience of remembering. Nat Rev Neurosci, 2:624–34.
Chawla, S. and Pichon, T.L. (2006) 2006 world drug report, Vienna, Austria, United Nations Office on Drugs and Crime.
Chen, J., Paredes, W., Lowinson, J.H. and Gardner, E.L. (1990) Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur J Pharmacol, 190:259–62.
D’Souza, D.C. (2007) Cannabinoids and psychosis. Int Rev Neurobiol, 78:289–326.
D’Souza, D.C., Abi-Saab, W.M., Madonick, S., et al. (2005) Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry, 57:594–608.
D’Souza, D.C., Perry, E., Macdougall, L., et al. (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology, 29:1558–72.
Daskalakis, Z.J., Christensen, B.K., Chen, R., Fitzgerald, P.B., Zipursky, R.B. and Kapur, S. (2002) Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry, 59:347–54.
Eichenbaum, H., Yonelinas, A.P. and Ranganath, C. (2007) The medial temporal lobe and recognition memory. Annu Rev Neurosci, 30:123–52.
Elphick, M.R. and Egertova, M. (2001) The neurobiology and evolution of cannabinoid signalling. Phil Trans R Soc Lond B, 356:381–408.
Fadda, P., Robinson, L., Fratta, W., Pertwee, R.G. and Riedel, G. (2004) Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats. Neuropharmacology, 47:1170–9.
Freedman, R., Adams, C.E., Adler, L.E., et al. (2000) Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia. Am J Med Genet, 97:58–64.
French, E.D. (1997) delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett, 226:159–62.
Guillin, O., Abi-Dargham, A. and Laruelle, M. (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol, 78:1–39.
Hall, W. and Degenhardt, L. (2007) Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry, 20:393–7.
Hall, W. and Solowij, N. (1998) Adverse effects of cannabis. Lancet, 352:1611–6.
Hannula, D.E. and Ranganath, C. (2008) Medial temporal lobe activity predicts successful relational memory binding. J Neurosci, 28:116–24.
Huddy, V.C., Aron, A.R., Harrison, M., Barnes, T.R., Robbins, T.W. and Joyce, E.M. (2009) Impaired conscious and preserved unconscious inhibitory processing in recent onset schizophrenia. Psychol Med, 39:907–16.
Ilan, A.B., Gevins, A., Coleman, M., Elsohly, M.A. and De Wit, H. (2005) Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behav Pharmacol, 16:487–96.
Isbell, H., Gorodetzsky, C.W., Jasinski, D., Claussen, U., von Spulak, F. and Korte, F. (1967) Effects of ( – )delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia, 11:184–8.
Julian, M.D., Martin, A.B., Cuellar, B., et al. (2003) Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience, 119:309–18.
Kaladjian, A., Jeanningros, R., Azorin, J.M., Grimault, S., Anton, J.L. and Mazzola-Pomietto, P. (2007) Blunted activation in right ventrolateral prefrontal cortex during motor response inhibition in schizophrenia. Schizophr Res, 97:184–93.
Kofalvi, A., Rodrigues, R.J., Ledent, C., et al. (2005) Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J Neurosci, 25:2874–84.
Lamers, C.T. and Ramaekers, J.G. (2001) Visual search and urban driving under the influence of marijuana and alcohol. Hum Psychopharmacol, 16:393–401.
Lisman, J.E., Coyle, J.T., Green, R.W., et al. (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci, 31:234–42.
Mathew, R.J. and Wilson, W.H. (1993) Acute changes in cerebral blood flow after smoking marijuana. Life Sci, 52:757–67.
Mathew, R.J., Wilson, W.H., Chiu, N.Y., Turkington, T.G., Degrado, T.R. and Coleman, R.E. (1999) Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatr Scand, 100:67–75.
Mathew, R.J., Wilson, W.H., Coleman, R.E., Turkington, T.G. and Degrado, T.R. (1997) Marijuana intoxication and brain activation in marijuana smokers. Life Sci, 60:2075–89.
Mathew, R.J., Wilson, W.H., Humphreys, D., Lowe, J.V. and Weithe, K.E. (1993) Depersonalization after marijuana smoking. Biol Psychiatry, 33:431–41.
Mathew, R.J., Wilson, W.H., Humphreys, D.F., Lowe, J.V. and Wiethe, K.E. (1992) Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab, 12:750–8.
Mathew, R.J., Wilson, W.H. and Tant, S.R. (1989) Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand, 79:118–28.
Mathew, R.J., Wilson, W.H., Turkington, T.G. and Coleman, R.E. (1998) Cerebellar activity and disturbed time sense after THC. Brain Res, 797:183–9.
Mathew, R.J., Wilson, W.H., Turkington, T.G., et al. (2002) Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. Psychiatry Res, 116:173–85.
Melges, F.T., Tinklenberg, J.R., Deardorff, C.M., Davies, N.H., Anderson, R.E. and Owen, C.A. (1974) Temporal disorganization and delusional-like ideation. Processes induced by hashish and alcohol. Arch Gen Psychiatry, 30:855–61.
Moore, T.H., Zammit, S., Lingford-Hughes, A., et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370:319–28.
Morrison, P.D., Zois, V., McKeown, D.A., et al. (2009) The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med, 39:1607–16.
Murray, R.M., Morrison, P.D., Henquet, C. and Di Forti, M. (2007) Cannabis, the mind and society: the hash realities. Nat Rev Neurosci, 8:885–95.
O’Leary, D.S., Block, R.I., Koeppel, J.A., et al. (2002) Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology, 26:802–16.
O’Leary, D.S., Block, R.I., Koeppel, J.A., et al. (2007) Effects of smoking marijuana on focal attention and brain blood flow. Hum Psychopharmacol, 22:135–48.
Pertwee, R.G. (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol, 153:199–215.
Puighermanal, E., Marsicano, G., Busquets-Garcia, A., Lutz, B., Maldonado, R. and Ozaita, A. (2009) Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci, 12:1152–8.
Ramaekers, J.G., Kauert, G., Theunissen, E.L., Toennes, S.W. and Moeller, M.R. (2009) Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol, 23:266–77.
Ramaekers, J.G., Kauert, G., van Ruitenbeek, P., Theunissen, E.L., Schneider, E. and Moeller, M.R. (2006) High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology, 31:2296–303.
Ranganathan, M. and D’Souza, D.C. (2006) The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl), 188:425–44.
Reichenberg, A. and Harvey, P.D. (2007) Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol Bull, 133:833–58.
Rey, J.M. and Tennant, C.C. (2002) Cannabis and mental health. BMJ, 325:1183–4.
Robbe, D., Montgomery, S.M., Thome, A., Rueda-Orozco, P.E., McNaughton, B.L. and Buzsaki, G. (2006) Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci, 9:1526–33.
Rogers, R.D. and Robbins, T.W. (2001) Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol, 11:250–7.
Ross, C.A., Margolis, R.L., Reading, S.A., Pletnikov, M. and Coyle, J.T. (2006) Neurobiology of schizophrenia. Neuron, 52:139–53.
Rubia, K., Russell, T., Bullmore, E.T., et al. (2001) An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophr Res, 52:47–55.
Seamans, J.K. and Yang, C.R. (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol, 74:1–58.
Sharp, D.J., Bonnelle, V., De Boissezon, X., et al. (2010) Distinct frontal systems for response inhibition, attentional capture, and error processing. Proc Natl Acad Sci USA, 107:6106–11.
Simons, J.S., Gilbert, S.J., Owen, A.M., Fletcher, P.C. and Burgess, P.W. (2005) Distinct roles for lateral and medial anterior prefrontal cortex in contextual recollection. J Neurophysiol, 94:813–20.
Solowij, N. and Michie, P.T. (2007) Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?J Psychiatry Neurosci, 32:30–52.
Solowij, N., Stephens, R.S., Roffman, R.A., et al. (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA, 287:1123–31.
Stokes, P.R., Mehta, M.A., Curran, H.V., Breen, G. and Grasby, P.M. (2009) Can recreational doses of THC produce significant dopamine release in the human striatum?Neuroimage, 48:186–90.
Tanda, G., Pontieri, F.E. and Di Chiara, G. (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science, 276:2048–50.
van Os, J. and Kapur, S. (2009) Schizophrenia. Lancet, 374:635–45.
Volkow, N.D., Gillespie, H., Mullani, N., et al. (1996) Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res, 67:29–38.
Voruganti, L.N., Slomka, P., Zabel, P., Mattar, A. and Awad, A.G. (2001) Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res, 107:173–7.
Wagner, A.D., Schacter, D.L., Rotte, M., et al. (1998) Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science, 281:1188–91.
Wise, L.E., Thorpe, A.J. and Lichtman, A.H. (2009) Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. Neuropsychopharmacology, 34:2072–80.
Zeineh, M.M., Engel, S.A., Thompson, P.M. and Bookheimer, S.Y. (2003) Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science, 299:577–80.